Skip to main content
Clinical Trials/ITMCTR2000002940
ITMCTR2000002940RecruitingPhase 1

Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)

China Academy of Chinese Medical Sciences0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 1) Comply with the diagnostic criteria for pneumonia caused by novel coronavirus infection in the Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 4);
  • 2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.

Exclusion Criteria

  • 1) Patients with particularly severe pneumonia caused by novel coronavirus infection.
  • 2) Patients whose initial onset time exceeds 5 days.
  • 3) Patients with severe primary respiratory disease.
  • 4) It is difficult to administer to patients by oral or nasal feeding.
  • 5) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.

Investigators

Similar Trials

Clinical Controlled Trial for Traditional... | Clinical Trial